Skip to main content

Day: February 9, 2021

Concentrix Creates Voice of the Customer Essentials Platform to Transform Customer Interactions

Concentrix’ Essentials platform—which builds on the success of its award-winning ConcentrixCX SaaS platform—helps businesses launch a superior Voice of the Customer (VOC) out-of-the-box solution delivering real-time feedback that helps optimize performance, improve interactions with clients, and create better brand experiences.FREMONT, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) — Concentrix (Nasdaq: CNXC), a leading global provider of customer experience (CX) solutions and technology, today announced the launch of VOC Essentials, a rapidly deployable and cost-effective solution that combines industry-leading software-as-a-service technology with preconfigured customer engagement best practices, enabling businesses to measure their customers’ experience and take action to delight them.Drawing on experience from working with hundreds...

Continue reading

Microchip Unveils First Fully Integrated Solution for Vehicle Ethernet Audio Video Bridging (AVB)

LAN9360 AVB audio endpoint helps to reduce development time, eliminating the need for stack integration and additional software and firmware developmentCHANDLER, Ariz., Feb. 09, 2021 (GLOBE NEWSWIRE) — As connected vehicles increasingly rely on Ethernet for network connectivity, smart technology is helping developers to streamline infotainment system development and quickly adapt to manufacturers’ evolving requirements. Microchip Technology Inc. (Nasdaq: MCHP) today announced the first hardware-based audio endpoint solution for AVB – the LAN9360, a single chip Ethernet controller with embedded protocols.Microchip’s LAN9360 audio endpoint controller interconnects vehicles’ infotainment devices including speakers, amplifiers, microphones, navigation systems, radio tuners and smart headrests with Ethernet AVB. The LAN9360 bridges audio...

Continue reading

Constellium Launches Cash Tender Offer For Any and All of its Outstanding 6.625% Senior Notes due 2025

PARIS, Feb. 09, 2021 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) (“Constellium” or the “Company”) today announced that it has commenced a cash tender offer (the “Tender Offer”) to purchase any and all of its outstanding 6.625% Senior Notes due 2025 (the “Notes”). The pricing terms for the Tender Offer are set forth below.____________________* Per $1,000 principal amount of the Notes. Tendering Holders will also receive accrued and unpaid interest to, but not including, the Settlement Date (as defined below) for the Notes purchased pursuant to the Tender Offer.The Tender Offer is currently scheduled to expire at 5:00 p.m., New York City time, on February 19, 2021, unless extended or earlier terminated by Constellium (the “Expiration Time”).Tenders of Notes pursuant to the Tender Offer may be validly withdrawn at or prior to the...

Continue reading

Constellium Provides Preliminary Fourth Quarter 2020 Results and to Report Full Year 2020 Results on February 25, 2021

PARIS, Feb. 09, 2021 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) today announced its preliminary fourth quarter 2020 results. The Company will announce its full year 2020 earnings results before market opening on Thursday, February 25, 2021.Based on preliminary unaudited information for the fourth quarter of 2020, Constellium anticipates the following results:Shipments of approximately 374 thousand tons, up 2% compared to Q4 2019Revenue of €1.24 billion to €1.25 billion, down 9% compared to Q4 2019Income before income tax of €11 million to €29 million, compared to €12 million in Q4 2019Adjusted EBITDA of €106 million to €116 million, down 4% to 12% compared to Q4 2019Net Cash Flow from Operating Activities of €327 million to €337 million in 2020Free Cash Flow of €150 million to €160 million in 2020Investor Conference Call and...

Continue reading

AREV Appoints Dr. Roscoe Moore to Join the Advisory Board

VANCOUVER, British Columbia, Feb. 09, 2021 (GLOBE NEWSWIRE) — AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (“AREV Brands”) is pleased to announce the appointment of Dr. Roscoe Moore DVM, MPH, PhD, Former Assistant United States Surgeon General to the Scientific Advisory Board for AREV Nanotec Brands Inc, to provide strategic planning for AREV drug discovery planning, as a Senior Scientific Advisor.Dr. Moore is a Board member of the Board of Advisors and the Board of Directors of the Global Virus Network at the Institute of Human Virology (IHV), University of Maryland Medical Center, According to the National Science Foundation, UMB’s budget for research and development in 2019 was $1.1 billion, ranking it 14th overall in the nation and 8th among all public institutions.The IHV is the first research institute in the U.S. to link...

Continue reading

Orion Energy Expands LED Lighting and Controls Solutions to Include Air Movement Products Incorporating Virus-Killing Ultraviolet Light

MANITOWOC, Wis., Feb. 09, 2021 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of LED lighting, controls and IoT systems, including turnkey project implementation, as well as ongoing system maintenance and program management, today announced plans to expand its product line to include a family of ceiling air movement solutions, some of which will incorporate LED lighting and others which will utilize ultraviolet C (UVC) light waves to kill viruses, bacteria and germs. Orion has entered into a licensing and exclusive manufacturing agreement with Go Fan Yourself to incorporate their patented air movement and UVC related technologies into its fixtures.Orion will be launching the following family of ISON-branded air movement products:ISON Air MovementISON Air Movement with LED lighting, andISON...

Continue reading

Invesco Ltd.: Form 8.3 – Arrow Global Group PLC Opening Position Disclosure

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Continue reading

Icanic Brands Expands California Brand Portfolio with Acquisition of De Krown Enterprises LLC

Icanic Brands has signed a binding LOI to acquire 100% of De Krown Enterprises LLCDe Krown Enterprises LLC generated $324,000 USD in revenue last quarter with 54% gross marginsDe Krown has an existing capacity to manufacture 118,000 pre-rolls per day over 2 shiftsVANCOUVER, British Columbia, Feb. 09, 2021 (GLOBE NEWSWIRE) — Icanic Brands Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Icanic Brands” or the “Company”), a multi-state brand operator of premium Cannabis brands in California and Nevada, is pleased to announce that the Company has signed a binding LOI to acquire De Krown Enterprises LLC (“De Krown”), a California based leading cannabis white label manufacturer and brand owner.De Krown is led by a team of successful and tenured executives from the California cannabis space as well as proven entrepreneurs in various other fields....

Continue reading

Constellium Launches Proposed Sustainability-Linked Senior Notes Offering

PARIS, Feb. 09, 2021 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) (“Constellium”) announced today the commencement of a proposed private offering of approximately $500 million of U.S. dollar denominated sustainability-linked senior unsecured notes due 2029 (the “Sustainability-Linked Notes”), subject to market and other conditions (the “Notes Offering”).Constellium, as part of its sustainability strategy, has established sustainability performance targets to (1) reduce its Scope 1 and Scope 2 greenhouse gas (GHG) emissions intensity to equal or lower than 0.615 of CO2 equivalent per metric ton of sales for the full year of 2025 and (2) increase its recycled aluminium input to equal to or higher than 685 thousand metric tons for the full year of 2026.Constellium intends to use the net proceeds of the Notes Offering, together with...

Continue reading

BioCryst to Present Data at 2021 American Academy of Allergy, Asthma & Immunology Annual Meeting

RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that data on ORLADEYO™ (berotralstat) will be presented at the 2021 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting, which is being held virtually from February 26-March 1, 2021.Berotralstat Reduces Use of On-demand Medication in Hereditary Angioedema (HAE) Patients Previously Treated with Prophylactic Therapies, Oral Abstract Presentation, Poster #465: February 27, 5:10pm-6:25pm ETDespite Prophylactic Treatments, Break-through Attacks Continue among Patients with Hereditary Angioedema, Poster #63Berotralstat Consistently Demonstrates Reductions in Attack Frequency in Hereditary Angioedema (HAE) Irrespective of Baseline Attack Rate: Subgroup Analysis from the APeX-2 Trial, Poster...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.